Shigefumi Yokota Selected Research

Shigefumi Yokota Research Topics

3	Insulin Resistance 01/2020 - 07/2013
2	Hypoxia (Hypoxemia) 01/2020 - 01/2016
1	Obesity 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Hypothermia 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hyperthermia 01/2020
1	Lentivirus Infections 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 08/2018
1	Muscular Atrophy (Muscle Atrophy) 08/2018
1	Hyperglycemia 01/2017
1	Hypercapnia 04/2015
1	Ganglion Cysts (Ganglion) 11/2013
1	Weight Gain 11/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2012
1	Liver Diseases (Liver Disease) 01/2011
1	Alzheimer Disease (Alzheimer's Disease) 11/2009

3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2013
2	ONO2506IBA 01/2020 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2011
2	LeptinIBA 01/2017 - 07/2013
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	NitrogenIBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	CarbohydratesIBA 01/2020
1	MyostatinIBA 08/2018
1	Steroidogenic Factor 1IBA 01/2017
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 11/2013
1	Melanocortin Receptors (Melanocortin Receptor)IBA 07/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2013
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 07/2013
1	salicylhydroxamic acid (SHAM)IBA 11/2012
1	Carrier Proteins (Binding Protein)IBA 03/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2012
1	Cystatin CIBA 03/2012
1	LipidsIBA 01/2011
1	Amyloid beta-PeptidesIBA 11/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2009
1	alpha-tocopherol transfer proteinIBA 11/2009
1	Vitamin E FDA LinkGeneric 11/2009

1	Induced Hypothermia 01/2020
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2020
1	Injections 04/2015